12:17 PM EST - Tekmira Pharmaceuticals Corp. : announced it expects to receive a minimum of $11.2 million over the next three years from its partner Alnylam Pharmaceuticals Inc. for process development and manufacturing services. Tekmira Pharmaceuticals Corp.
shares T.TCS are trading unchanged at $1.30.
